New England Biolabs® Launches NEBNext® Enzymatic Methyl-seq (EM-seq™) for bisulfite-free methylation analysis
This new enzyme-based system allows scientists to accurately and sensitively assess DNA methylation without bisulfite treatment, for epigenetics research. IPSWICH, MA (April 29, 2019) — New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis. Bisulfite treatment has long been the gold standard for... Read more